Thomas Stroemquist is a seasoned professional in the pharmaceutical and biotechnology sectors, currently serving as Senior Director at Gilead Sciences since April 2018, where responsibilities include heading Major Markets and Systems for publishing. Previously, Thomas held significant roles in regulatory operations at Sobi - Swedish Orphan Biovitrum AB, including Associate Director and Section Manager, focusing on European publishing and regulatory compliance. Early career experience includes positions at Swedish Orphan Biovitrum, Amersham Biosciences, and Biovitrum, emphasizing chromatography, process development, and regulatory affairs. Thomas holds a Master of Science in Biotechnology from Linköping University and is a Registered Nurse trained at Vårdhögskolan i Sundsvall.
This person is not in the org chart
This person is not in any teams
This person is not in any offices